ISSUE 3 - SUMMER 2002

Why Didn’t I Think Of That? Seven Symptoms of Incremental Thinking and How to Treat Them

Andrew Razeghi

 

Table of Contents
Current Issue
Issue Archive
Contributor Biographies
About Virtual Strategist
Connections

 

Click here if you would like an email notification when future issues are published.


Get Acrobat Reader here!

The Virtual Strategist is published by VirtualStrategist.net LLC. All contents are protected by Copyright © 2002.

By entering this site, you are agreeing to the terms and conditions of use.

 

Web design and development by:

  Click here to download this article in PDF format.

Page 3

6.  SHOW THEM THE MONEY AND THEN GIVE IT TO THEM

The sixth symptom of idea rigor mortis is evident from shallow employee incentive programs.  In the wake of Enron and Arthur Andersen, gone are the days of corporate loyalty.  While there will continue to be a modicum of pride amongst employees, for employers, patents and passion will continue to hang more proudly in garages than in R&D labs.  The greatest challenge in the wake of recent business failures, where employees were personally rewarded for new ideas, is to recognize that the desire to “own” ideas will not subside although incentive stock option programs may.  While ill-structured incentive programs can derail innovation, so too can shallow employee incentive programs where employees are treated as vendors instead of customers.  Overcoming this barrier to innovation requires a behavioral and attitudinal shift about the role of employees.   

There are a wide array of options available to organizations for rewarding innovation, these include:

  • Offer year-end cash bonuses for successful experiments
  • Create phantom stock options that track firm performance
  • Package and subsidize employee learning sabbaticals
  • Encourage “resisters” to critically improve versus critically reject by offering monetary and non-monetary incentives to those that contribute as adjunct experts
  • Evaluate and “sponsor” ideas of organization alumni (if strategic fit with core business, yet the organization does not want to invest human capital and internal resources)

7.  MEASURE RETURNS ON LEARNING AS OFTEN AS RETURNS ON EQUITY

While much has been written about the importance of experimentation and “controlled failure” in innovation processes, little has been developed for the measurement of returns on experiments. 

In other words, without the proper metrics for measuring learning, organizations often kill new ideas due to their inability to deliver on the requisite ROI common to most budgeting processes.  This is often revealed by organizations that maintain a high income to revenue growth ratio.  Organizations that have sustained income to revenue growth over a multi-year period are more likely to experience earnings collapse than those with lower ratios (Hamel).  The logic is quite simple.  At some point, the earnings engine becomes anemic due to issues such as staff layoffs, budget cuts, and plant closures.  While all necessary tactics of operating and maintaining the enterprise, there are considerable risks associated with denominator management over a longer period of time.   In fact, Professor Gary Hamel of The London Business School discovered that firms who displayed income to revenue growth of greater than 3:1 consecutively over a five year period have over 80% chance of earnings collapse in the fifth year.  Professor Hamel’s insight surfaced from studying the performance of the companies that comprise the S&P 500 Index and their respective income growth to revenue growth performance over a 5-year period. The point is, organizations must vigorously pursue innovation as a component of their overall corporate strategy and invest in new product and service development in search of new wealth creation. 

In order to alleviate this symptom, organizations must create new metrics to measure learning.  By measuring Returns on Learning, innovative new ideas will be given the requisite time to incubate and materialize as they were originally intended.  For example, in many large organizations, new products must contribute to a minimum percentage of sales within a given time frame (e.g. 2% of sales within 18 months) in order to be considered a successful product introduction or addition.  The downside of this type of metric is that the new product may very well appeal to a nascent, yet growing, customer segment that may take 5 years to develop.  For example, the organic foods movement is the fastest growing segment in the food industry (eg. Whole Foods is growing at 20% year-over-year); although it contributes to an overall minority of total food sales.  In the near-term this market may not seem as attractive as processed food; therefore, it requires new metrics to measure its relevance as the segment grows.  These metrics may include:

  • Brand elasticity.  What are “accepted” levels of product innovation among customers?  What will they “believe”? (e.g. Nike car tires?  Organic Foods from Quaker Oats?)
  • Customer acquisition costs (e.g. SG&A expenses are a great indicator of product relevance as great ideas are bought not sold.  Experiments are great methods for extrapolating marketing and selling expenses associated with a new product introduction, e.g. online viral marketing communities as highly-leveraged sales forces for record labels, book publishers, clothiers, and image branding concepts)
  • Concept development (i.e. how did the experiment contribute to the approval or disapproval of working hypotheses about the business model?)

In closing, all organizations have the capacity to overcome incrementalism, think innovatively, and adopt continuous innovation as an enterprise-wide capability.  In short, by identifying areas within the organization where these 7 symptoms may reside, the organization can begin to apply new methods, new perspectives, and new questions to the process of strategy creation.  Most importantly, organizations that identify these common pitfalls in their own thinking will be able to embed innovation as a core competency (as they did with quality, continuous improvement, and knowledge management in years past).  The objective is to think of this and that more often, in a more structured fashion, and for the betterment of all stakeholders.  This leaves only one question, what are the growth strategies available to organizations once they’ve treated the symptoms of incremental thinking?  What does the organization do once it has acquired a new method of thinking?  Stay tuned in the next edition for “Smart Growth: From the Core to New Markets”.   

Now, get to work.  You’ve got that to think about!  

SUGGESTED READING:

Competing for the Future; Hamel, Gary; Prahalad, C.K., Harvard Business School Press, 1996  

The Alchemist; Coelho, Pablo; Harper San Francisco; 1993;  

The Art of Innovation; Kelley, Tom; Doubleday; 2001

“In Search of Relevance: The Innovation Imperative”; Razeghi, Andrew; www.strategylab.com

<<Back to Page 2